Latest biotech News | Page 10

Imugene licenses allogeneic CAR-T with a potential registration study in 2024
CUREator+ delivers funding boost to commercially focused BioMedTech startups
AusBiotech 2023 programme launched
Chimeric reports positive in-vitro data for CHM 0301 next-generation cell platform
CSL reports strong profit growth with record plasma collections
A major day for Moderna as the company builds its Australian presence
AusBiotech 2023 Millis Orator announced
Notification of AGM 2023 and forthcoming elections
Clarity’s theranostic prostate cancer trial advances to highest dose level
Merck partners to pilot first DeadlyLabs kit
Australian vaccine breakthrough offers hope against EBV-associated cancers and MS
AusBiotech launches world-first ESG Guide for biotech SMEs
AusBiotech weighs in on Industry Growth Program consultation
Dimerix announces successful completion of second DSMB review of ACTION3 trial
Peter Mac selects BindiMaps to launch Victoria’s first hospital ‘Google Maps for indoors’
Immutep receives positive scientific advice from the European Medicines Agency
New AusBiotech report shows increasing US investment in Australian biotechs
Allarity Therapeutics and FivepHusion announce collaboration for the development of Deflexifol with DRP Companion Diagnostics
AusBiotech responds to research funds consultation
Chimeric receives patent allowance for chlorotoxin in Japan
Neuren Pharmaceuticals wins Bioshares Excellence Award
Dimerix updates on expected timing of DMX-200 Phase 3 kidney trial outcome
Report reviewing gender equity initiatives launched
First patient dosed in study of Telix’s TLX250 with Merck’s peposertib
BioCurate in new partnership with the European Healthtech Venture Builder
Australian company collaborates on US launch of prostate cancer diagnostic
AusBiotech launches National Cell and Gene Manufacturing Blueprint
Industry-led cell and gene manufacturing strategy to develop Australia as APAC hub launched
Henry Schein Medical expands distribution partnership with Lumos Diagnostics
Actinogen CMO presents academic poster to Alzheimer’s Association International Conference
Sensible approach for medtech clinical trials
Pharmaxis reports positive analysis of data from phase 2 PXS-5505 study
Victoria invites expressions of interest for Industry R&D Infrastructure Fund grants
Early-Stage Innovation Forum opens
Lumos completes placement and launches share purchase plan
First cohort dosed in RECCE 327 rapid infusion UTI clinical trial
Build your profile through BiotechDispatch
Moderna submits RSV vaccine to global regulatory agencies
Genetic discovery could help prevent irreversible blindness in people with glaucoma
AusBioNSW General Manager appointed
Cynata Therapeutics announces CEO succession and board changes
Nutromics to progress wearable diagnostic platform with latest capital raise
Takeda’s COCKPI-T programme calls for applications
Neuren opens first site in US for Prader-Willi syndrome Phase 2 trial
AusBiotech calls for journal articles
Government proposes improved GMO regulations to encourage health research
Imagion Biosystems announces appointment of new CEO
The new ‘Jumar Bioincubator’ calls for biotechnology start-ups